Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.
Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, Araki N, Kudawara I, Ieguchi M, Nakamura K, Nakamura Y, Matsuda K.
Morioka K, et al. Among authors: matsuda k.
Cancer Sci. 2009 Jul;100(7):1227-33. doi: 10.1111/j.1349-7006.2009.01165.x. Epub 2009 Apr 15.
Cancer Sci. 2009.
PMID: 19486338
Free PMC article.